Story by: Norton Healthcare on October 15, 2020
More widespread use of plasma from recovered COVID-19 patients is sapping the area’s supply of the blood product to treat severely and critically ill patients.
Once available only through a clinical trial, convalescent plasma now has Food and Drug Administration authorization for wider use as a COVID-19 treatment. The plasma carries antibodies from recovered patients that can help fight the virus in others.
If you think you are eligible to donate you have two choices.
Call (502) 446-2688
Additional requirements, such as those associated with any blood donation, also apply.
As an experimental treatment, the convalescent plasma procedure is available only to patients who are severely ill from the disease. Convalescent plasma has been used over the past several years to treat severe illnesses such as severe acute respiratory syndrome (SARS), avian influenza and Ebola virus.
If you think you are eligible to participate, you have two ways to become a plasma donor:
Select an appointment date and time from available spots listed below.